Share Facebook Twitter LinkedIn Pinterest Email Orrstown Financial Non-GAAP EPS of $0.87, revenue of $61.82M
AngioDynamics signals FY2026 adjusted EBITDA of $10M-$12M while raising net sales guidance to $313.5M-$315.5M (NASDAQ:ANGO)April 2, 2026